Fundraising Fox
Find your path to Mohan
503 people in our graph can introduce you to Mohan.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jason Lettmann to introduce you to Mohan
You →Jason · together at Second Genome, Inc. (2012–2017) →Mohan
Ask Jamie Chen to introduce you to Mohan
You →Jamie · together at Second Genome, Inc. →Mohan
Ask Sam Okafor to introduce you to Mohan
You →Sam · 5 people · together at Burrill & Company →Mohan
Sign up to find every way you can get introduced to Mohan
- Your email: the people you already email who know Mohan
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Mohan
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
General Partner at SOSV who mentors first-time founders and shares operating experience with them.
Board director at Cellens
Intro paths
In turn, Mohan can intro founders to Cellens's investors below.
Cellens's investors · 3
Co-founders at Cellens
Experience
- IndieBioGeneral Partnercurrent2021 — presentSan Francisco, California, United States
- Pendulum TherapeuticsCOO2017 — 2021
- Second Genome, Inc.Chief Business Officer2012 — 2017
- Tethys Bioscience, Inc.CFO2011
- Tethys Bioscience, Inc.Chief Business Officer2009 — 2011
- Burrill & CompanyManaging Director, Merchant Banking2006 — 2009
- diaDexusEVP, Corporate and Business Development1997 — 2005
- The Wilkerson Group (IBM Healthcare Consulting)Senior Healthcare Consultant1995 — 1997
- Genentech Inc.Senior Process Engineer1986 — 1993
Skills & more
+12 more
OncologyClinical DevelopmentDue DiligenceProduct LaunchDrug DiscoveryMergers & AcquisitionsGlobal MarketingStrategic PartnershipsDrug DevelopmentCross-functional Team LeadershipR&DBiopharmaceuticalsLanguages Tamil
From Mohan's professional profile.
Investments
Investor
AntarkaAugment BiologicsBlaze Energy TechnologiesCalifornia Perovskite TechnologyCellensDisperseBioEndarisFermeateFinish Line BioFLOUVGilly BiotechnologiesInixi BioLambda energyLogos AIMetabolic Psychiatry LabsMetabolizeOncoPrecisionPost Translational MedicinesProton IntelligenceReefstarterSupercool EarthSynplexitySyntheXTransitionmetalUnlocked LabsXtelligence
Per curated public sources.
Colleagues at IndieBio
Frequently asked questions
- Who is Mohan S. Iyer?
- General Partner at SOSV who mentors first-time founders and shares operating experience with them.
- Where does Mohan S. Iyer work?
- Mohan S. Iyer is General Partner at IndieBio and Board director at Cellens.
- What check size does Mohan S. Iyer write?
- Mohan S. Iyer typically writes checks of $100K – $2M.
- What companies has Mohan S. Iyer invested in?
- Investments tracked here include Antarka, Augment Biologics, Blaze Energy Technologies, California Perovskite Technology, Cellens, DisperseBio, Endaris, Fermeate, Finish Line Bio, FLOUV, Gilly Biotechnologies, Inixi Bio, and 14 more.
- Where did Mohan S. Iyer go to school?
- Mohan S. Iyer studied at Yale School of Management (MBA); Duke University (MS, Biomedical Engineering); University of Tennessee, Knoxville (B.S., Chemical Engineering).
Same school
Also attended Yale School of Management264
+ 258 more
Also attended Duke University1,036
+ 1,030 more
Also attended University of Tennessee, Knoxville123
+ 117 more
Also attended Duke University Graduate School2
Shared employers
Also worked at Pendulum Therapeutics4
Also worked at Second Genome, Inc.5
Also worked at diaDexus3
Also worked at Genentech Inc.259
+ 253 more